The largest database of trusted experimental protocols

6 protocols using azilsartan

1

Azilsartan's Antiproliferative Effects on Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability assay was achieved using MTT reagent [3-(4, 5-dimethyl thiazol-2yl)-2, 5-diphenyltetrazolium bromide]. MCF-7, MDA-MB-231 or MCF 10A cells (104 cells per well) were seeded in triplicate in 96-well plates and allowed to grow in fresh DMEM medium for 24 h. Then, medium was changed with fresh DMEM containing different concentrations (7.81, 15.61, 31.25, 62.5, 125, 250, 500 and 1000 μg/mL) of azilsartan (Sigma-Aldrich, Inc., St Louis, MO, USA). After 48 h, 10 μL of MTT (5 μg/mL) was added per well and incubated in the dark for 3 h at 37 °C. To dissolve the Formazan crystals that were formed, 100 μL of DMSO was used, and absorbance was measured using an ELISA reader at 570 nM [66 (link)]. The IC50 of azilsartan was calculated for each cell line using Graph Pad Prism-9 software for macOS (GraphPad version 9.4.1 (458), La Jolla, CA, USA).
+ Open protocol
+ Expand
2

Azilsartan Attenuates Ox-LDL-Induced HUVEC Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the experiments were designed in accordance with the “World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects”. The study was approved by the Ethical Committee of Ganzhou People’s Hospital (GZH-2017021). HUVECs were purchased from the Type Culture Collection of the Chinese Academy of Sciences (TCCCAS, Shanghai, China) and cultured with an EGM-2 Bullet Kit (Lonza, Switzerland) containing 0.1% gentamicin sulfate (GA-1000). HUVECs were routinely maintained in 2% low serum complete growth media EGM2 for less than seven passages, and all cultures were maintained in a humidified 37° C atmosphere. Azilsartan (98% purity) was purchased from Sigma-Aldrich, MO, USA (#SML0432), and Ox-LDL from Thermo Fisher Scientific, MA, USA (#L34357). For treatment experiments, HUVECs were plated on 35 or 60-mm dishes at a density of 2x104 cells/cm2 area overnight, HUVECs were treated with Ox-LDL (100 μg/ml) [18 (link), 19 (link)] in the presence or absence of Azilsartan (3, 6 μM) [17 (link)] for 24 hours.
+ Open protocol
+ Expand
3

Mouse Inflammatory Response Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male C57BL6/J mice that were eight to ten weeks old were acquired from CLEA Japan, Inc. (Tokyo, Japan) and maintained at an animal facility. The Science Animal Care and Use Committee of Tohoku University’s guidelines were followed in full for all animal care and experimental procedures. Each experimental group consisted of four randomly assigned mice. Azilsartan was purchased from Sigma-Aldrich (St. Louis, MO) and dissolved in DMSO before being kept at 4°C. LPS from Escherichia coli were bought from Sigma-Aldrich (St. Louis, MO). As previously mentioned, recombinant murine TNF-α (38 (link)) and M-CSF (CMG14-12 cell line) (39 (link)) were produced.
+ Open protocol
+ Expand
4

Anti-Acanthamoeba Activity of PARP Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Obtained from TargetMol (Wellesley Hills, MA, USA), talazoparib, AZD2461, azilsartan, trovafloxacin, olaparib, and venadaparib were dissolved in 100% dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO, USA). AZ9482 was obtained from MCE (MedChem Express, Monmouth Junction, NJ). Although talazoparib, AZ9482, AZD2461, azilsartan, and trovafloxacin were prepared at 10 mM concentrations, olaparib, venadaparib and AZ9482 were prepared at 200 mM concentrations. A. castellanii trophozoites were seeded at the log growth phase (10 4 trophozoites per well) in a 96-well white microplate (Eppendorf, Hamburg, Germany). Incubation with medium containing varied olaparib, venadaparib and AZ9482 concentrations (100, 200, 300, 400 , and 500 mM) was performed for 24 h, 48 h and 72 h at 26°C. Trophozoites viability assay results, derived from at least three wells per condition and compared with diluted DMSO, were
+ Open protocol
+ Expand
5

Azilsartan Modulates Osteoclast Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Azilsartan was obtained from Selleck Chemicals (Selleck Chemicals, Houston, TX, United States). Azilsartan was dissolved in DMSO (Sigma–Aldrich, Sydney, Australia) and stored at −20°C until use. Fetal bovine serum (FBS) and α-MEM were purchased from Gibco (Gaithersburg, MD, United States). Recombinant M-CSF and RANKL were purchased from R&D Systems (Minneapolis, MN, United States). Specific antibodies against c-Fos, CTSK, NFATc1, GAPDH, β-actin and HO-1 were purchased from Abcam (Cambridge, United Kingdom). Antibodies against p-JNK, JNK, p-ERK, ERK, p-P38, P38, p-IκBα, IκBα, p-P65, P65, and Nrf2 were purchased from Cell Signaling Technology (Danvers, MA, United States). Cell Counting Kit-8 (CCK-8) was purchased from Solarbio Science and Technology (Solarbio, Beijing, China).
+ Open protocol
+ Expand
6

Evaluating Neuroprotective Potential of Perindopril and Azilsartan

Check if the same lab product or an alternative is used in the 5 most similar protocols
Perindopril and azilsartan were procured from Sigma Aldrich, (CO., Saint Louis, MO, USA). Sodium- Carboxymethyl cellulose (Na-CMC) was obtained from the faculty of pharmacy at King Abdulaziz University. Aluminum chloride (AlCl3) was obtained from KFCMR at King Abdulaziz University. Rat ELISA kits for the determination of beta-amyloid Peptide - 42 (Aβ-42) and Nitric Oxide (NO) were bought from (SunLong Biotech Co. China). Tumor necrosis factor (TNF-α), Malondialdehyde (MDA) and Acetylcholinesterase (AChE) were purchased from (Elabscience Co. USA)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!